Literature DB >> 10525516

Evolution and long term outcome in cases with fetal diagnosis of congenital heart disease: Italian multicentre study. Fetal Cardiology Study Group of the Italian Society of Pediatric Cardiology.

V Fesslova'1, S Nava, L Villa.   

Abstract

OBJECTIVES: To analyse the evolution and outcome in utero and after birth of infants with a fetal diagnosis of congenital heart disease.
DESIGN: Inclusion criteria were the fetal diagnosis of congenital heart disease, confirmed postnatally or postmortem, and a complete follow up in utero and after birth.
SETTING: 20 centres operating prenatal echocardiographic screening. PATIENTS: 847 cases were included in the study. Gestational age at diagnosis ranged from 15-39 weeks; in 370 cases (43.7%) the diagnosis was made before 24 weeks' gestation.
RESULTS: 245/847 cases (28.9%) were terminated during pregnancy, 227 following early diagnosis; 128/245 cases (52. 2%) had associated anomalies and 117/245 (47.8%) had serious congenital heart disease. Of the remaining 602 cases that continued the pregnancy, 72 (11.9%) died in utero, 259 (43%) died postnatally (83 after surgery or invasive procedures), and 271 infants (45%) survived and presently range in age from 18 months to 13 years old. The mortality rate was higher in cases with associated extracardiac or chromosomal anomalies (68% and 74% of cases continuing pregnancy, respectively), and in cases with heart failure and complex cardiac defects.
CONCLUSIONS: The data confirm a relevant fetal and postnatal loss in cases with complex congenital heart disease, and major clinical use of prenatal diagnosis in the management of ductus dependent anomalies. Negative prognostic factors for the outcome were associated anomalies and heart failure.

Entities:  

Mesh:

Year:  1999        PMID: 10525516      PMCID: PMC1760776          DOI: 10.1136/hrt.82.5.594

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  24 in total

1.  The natural history of the hypoplastic left heart syndrome.

Authors:  L D Allan; G Sharland; M J Tynan
Journal:  Int J Cardiol       Date:  1989-12       Impact factor: 4.164

2.  Fetal echocardiography: a large clinical experience and follow-up.

Authors:  G R Martin; R N Ruckman
Journal:  J Am Soc Echocardiogr       Date:  1990 Jan-Feb       Impact factor: 5.251

3.  Prenatal screening for congenital heart disease.

Authors:  L D Allan; D C Crawford; S K Chita; M J Tynan
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-28

4.  Perinatal outcome of fetal complete atrioventricular block: a multicenter experience.

Authors:  K G Schmidt; H E Ulmer; N H Silverman; C S Kleinman; J A Copel
Journal:  J Am Coll Cardiol       Date:  1991-05       Impact factor: 24.094

5.  Extracardiac abnormalities in infants with congenital heart disease.

Authors:  R D Greenwood; A Rosenthal; L Parisi; D C Fyler; A S Nadas
Journal:  Pediatrics       Date:  1975-04       Impact factor: 7.124

6.  Fetal atrioventricular valve insufficiency associated with nonimmune hydrops: a two-dimensional echocardiographic and pulsed Doppler ultrasound study.

Authors:  N H Silverman; C S Kleinman; A M Rudolph; J A Copel; E M Weinstein; M A Enderlein; M Golbus
Journal:  Circulation       Date:  1985-10       Impact factor: 29.690

7.  Spectrum of congenital heart disease detected echocardiographically in prenatal life.

Authors:  L D Allan; D C Crawford; R H Anderson; M Tynan
Journal:  Br Heart J       Date:  1985-11

8.  Familial recurrence of congenital heart disease in a prospective series of mothers referred for fetal echocardiography.

Authors:  L D Allan; D C Crawford; S K Chita; R H Anderson; M J Tynan
Journal:  Am J Cardiol       Date:  1986-08-01       Impact factor: 2.778

9.  Tricuspid valve disease with significant tricuspid insufficiency in the fetus: diagnosis and outcome.

Authors:  L K Hornberger; D J Sahn; C S Kleinman; J A Copel; K L Reed
Journal:  J Am Coll Cardiol       Date:  1991-01       Impact factor: 24.094

10.  Fetal echocardiography for evaluation of in utero congestive heart failure.

Authors:  C S Kleinman; R L Donnerstein; G R DeVore; C C Jaffe; D C Lynch; R L Berkowitz; N S Talner; J C Hobbins
Journal:  N Engl J Med       Date:  1982-03-11       Impact factor: 91.245

View more
  14 in total

Review 1.  The changing epidemiology of congenital heart disease.

Authors:  Teun van der Bom; A Carla Zomer; Aeilko H Zwinderman; Folkert J Meijboom; Berto J Bouma; Barbara J M Mulder
Journal:  Nat Rev Cardiol       Date:  2010-11-02       Impact factor: 32.419

2.  Impact of fetal counseling on outcome of antenatal congenital surgical anomalies.

Authors:  Shilpa Sharma; Ranjana Bhanot; Dipika Deka; Minu Bajpai; Devendra K Gupta
Journal:  Pediatr Surg Int       Date:  2016-11-18       Impact factor: 1.827

Review 3.  The impact of fetal echocardiography on the prevalence of liveborn congenital heart disease.

Authors:  Ioannis Germanakis; Stavros Sifakis
Journal:  Pediatr Cardiol       Date:  2006-07-06       Impact factor: 1.655

4.  Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates.

Authors:  K L Brown; D A Ridout; A Hoskote; L Verhulst; M Ricci; C Bull
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

5.  Survival and Associated Risk Factors for Mortality Among Infants with Critical Congenital Heart Disease in a Developing Country.

Authors:  Mohd Nizam Mat Bah; Mohd Hanafi Sapian; Mohammad Tamim Jamil; Amelia Alias; Norazah Zahari
Journal:  Pediatr Cardiol       Date:  2018-05-14       Impact factor: 1.655

6.  Increased morbidity and mortality in very preterm/VLBW infants with congenital heart disease.

Authors:  Angelo Polito; Simone Piga; Paola E Cogo; Carlo Corchia; Virgilio Carnielli; Monica Da Frè; Domenico Di Lallo; Isabella Favia; Luigi Gagliardi; Francesco Macagno; Silvana Miniaci; Marina Cuttini
Journal:  Intensive Care Med       Date:  2013-03-28       Impact factor: 17.440

7.  Features and outcomes in utero and after birth of fetuses with myocardial disease.

Authors:  Vlasta Fesslova; Maurizio Mongiovì; Salvatore Pipitone; Jelena Brankovic; Laura Villa
Journal:  Int J Pediatr       Date:  2010-10-03

8.  Role of health insurance on the survival of infants with congenital heart defects.

Authors:  James E Kucik; Cynthia H Cassell; Clinton J Alverson; Pamela Donohue; Jean Paul Tanner; Cynthia S Minkovitz; Jane Correia; Thomas Burke; Russell S Kirby
Journal:  Am J Public Health       Date:  2014-07-17       Impact factor: 9.308

9.  Community socioeconomic disadvantage and the survival of infants with congenital heart defects.

Authors:  James E Kucik; Wendy N Nembhard; Pamela Donohue; Owen Devine; Ying Wang; Cynthia S Minkovitz; Thomas Burke
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

10.  Early administration of enzyme replacement therapy for Pompe disease: short-term follow-up results.

Authors:  M A Hamdan; M H Almalik; H M Mirghani
Journal:  J Inherit Metab Dis       Date:  2008-12-12       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.